Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRR1 | P24046 | 1/20 | 0.57 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | HRH2 | P25021 | 1/20 | 0.47 |
| ▸ | HRH1 | P35367 | 1/20 | 0.47 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.47 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | GRIA2 | P42262 | 7/20 | 0.45 |
| ▸ | GRIA1 | P42261 | 6/20 | 0.45 |
| ▸ | GRIA3 | P42263 | 6/20 | 0.45 |
| ▸ | GRIA4 | P48058 | 6/20 | 0.45 |
| ▸ | GRIK1 | P39086 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2815963 | 1.00 | GABRR1 (0.57) | GABRR1SLC7A5CYP3A4HRH2HRH1 | |
| Hydrochloric Acid SCHEMBL25273661 | 0.98 | GABRR1 (0.56) | GABRR1SLC7A5CYP3A4HRH2HRH1 | |
| SCHEMBL22070455 | 0.83 | GABRR1 (0.49) | GABRR1HRH2HRH1HRH4HRH3 | |
| SCHEMBL5795472 | 0.81 | SLC7A5 (0.46) | GABRR1SLC7A5CYP3A4GRIA2GRIA1 | |
| SCHEMBL5795467 | 0.81 | SLC7A5 (0.46) | GABRR1SLC7A5CYP3A4GRIA2GRIA1 | |
| SCHEMBL8697806 | 0.80 | SLC7A5 (0.49) | GABRR1SLC7A5CYP3A4TDP1GRIA2 | |
| SCHEMBL7535154 | 0.80 | SLC7A5 (0.49) | GABRR1SLC7A5CYP3A4TDP1GRIA2 | |
| SCHEMBL17002134 | 0.80 | SLC7A5 (0.49) | GABRR1SLC7A5CYP3A4TDP1GRIA2 | |
| SCHEMBL8701267 | 0.80 | SLC7A5 (0.49) | GABRR1SLC7A5CYP3A4TDP1GRIA2 | |
| SCHEMBL17293243 | 0.80 | SLC7A5 (0.49) | GABRR1SLC7A5CYP3A4TDP1GRIA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2023-08-17 | — | — | US | claimed |
| US-12565517-B2 | Cyclic peptide having CTLA-4 inhibitory activity and use thereof | GENEFRONTIER CORPORATION (JP) | 2026-03-03 | — | — | US | disclosed |
| WO-2026040002-A1 | COMPOSITION AND METHOD FOR CARING FOR THE SKIN | L'OREAL (FR) | 2026-02-26 | — | — | WO | disclosed |
| US-20240092836-A1 | CYCLIC PEPTIDE HAVING CTLA-4 INHIBITORY ACTIVITY AND USE THEREOF | GENEFRONTIER CORPORATION (JP) | 2024-03-21 | — | — | US | disclosed |
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2023-08-17 | — | — | US | disclosed |
| CN-114599389-A | Variant FC domains and uses thereof | 奇达拉治疗公司 | 2022-06-07 | — | — | CN | disclosed |
| US-20100249042-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF EYELASHES AND EYEBROWS | PROCYTE CORPORATION (US) | 2010-09-30 | — | — | US | disclosed |
| EP-1613302-B1 | PRESERVED AND STABLE COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND METHODS RELATED THERETO | PROCYTE CORP (US) | 2009-12-23 | — | — | EP | disclosed |
| US-20080255032-A1 | METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING AGING OR PHOTODAMAGED SKIN | PROCYTE CORPORATION (US) | 2008-10-16 | — | — | US | disclosed |
| US-7384916-B2 | Methods and compositions for preventing and treating aging or photodamaged skin | PROCYTE CORPORATION (US) | 2008-06-10 | — | — | US | disclosed |
| US-20040214749-A1 | Compositions and methods for treatment of psoriasis | PROCYTE CORPORATION (US) | 2004-10-28 | — | — | US | disclosed |
| WO-2004087740-A2 | PRESERVED AND STABLE COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND METHODS RELATED THERETO | PROCYTE CORPORATION (US) | 2004-10-14 | — | — | WO | disclosed |
| US-20040198639-A1 | Preserved and stable compositions containing peptide copper complexes and methods related thereto | PROCYTE CORPORATION | 2004-10-07 | — | — | US | disclosed |
| US-20040142853-A1 | Stimulation of hair growth by compositions containing peptide copper complexes and minoxidil | PROCYTE CORPORATION | 2004-07-22 | — | — | US | disclosed |
| WO-2004043415-A1 | STIMULATION OF HAIR GROWTH BY COMPOSITIONS CONTAINING PEPTIDE COPPER COMPLEXES AND MINOXIDIL | PROCYTE CORPORATION (US) | 2004-05-27 | — | — | WO | disclosed |
| EP-0765152-B1 | STIMULATION OF HAIR GROWTH BY PEPTIDE-COPPER COMPLEXES | PROCYTE CORP (US) | 2001-11-07 | — | — | EP | disclosed |
| US-6017888-A | Stimulation of hair growth by peptide copper complexes | PROCYTE CORPORATION (US) | 2000-01-25 | — | — | US | disclosed |
| EP-0765152-A1 | STIMULATION OF HAIR GROWTH BY PEPTIDE-COPPER COMPLEXES | PROCYTE CORPORATION (US) | 1997-04-02 | — | — | EP | disclosed |
| US-5538945-A | Stimulation of hair growth by peptide copper complexes | PROCYTE CORPORATION (US) | 1996-07-23 | — | — | US | disclosed |
| WO-1995035085-A1 | STIMULATION OF HAIR GROWTH BY PEPTIDE-COPPER COMPLEXES | PROCYTE CORPORATION (US) | 1995-12-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240092836-A1 | CYCLIC PEPTIDE HAVING CTLA-4 INHIBITORY ACTIVITY AND USE THEREOF | CXCL10, CXCR3, CXCR6 | GABRR1 3152/4885SLC7A5 1763/4885CYP3A4 2636/4885 |
| US-12565517-B2 | Cyclic peptide having CTLA-4 inhibitory activity and use thereof | CXCL10, MLX, MICA | GABRR1 2488/4885SLC7A5 1811/4885CYP3A4 2921/4885 |
| US-20040142853-A1 | Stimulation of hair growth by compositions containing peptide copper complexes and minoxidil | PDGFA, FGF1, FGF2 | GABRR1 2969/4885SLC7A5 1616/4885CYP3A4 4276/4885 |
| US-20100249042-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF EYELASHES AND EYEBROWS | CUTA, TYR, EYA3 | GABRR1 1368/4885SLC7A5 1624/4885CYP3A4 4834/4885 |
| US-20040214749-A1 | Compositions and methods for treatment of psoriasis | TYR, CUTA, ETF1 | GABRR1 2156/4885SLC7A5 2905/4885CYP3A4 3746/4885 |
| US-20230257343-A1 | NOVEL AMINO ACID DERIVATIVES | DNPEP, BCAT1, ANPEP | GABRR1 2794/4885SLC7A5 21/4885CYP3A4 4397/4885 |
| US-20040198639-A1 | Preserved and stable compositions containing peptide copper complexes and methods related thereto | AOC1, NONO, CUTA | GABRR1 3356/4885SLC7A5 2928/4885CYP3A4 3027/4885 |
| US-20080255032-A1 | METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING AGING OR PHOTODAMAGED SKIN | RBP1, RBP4, SOD1 | GABRR1 3755/4885SLC7A5 1876/4885CYP3A4 4549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.